Table 2 Summary of the percentage of hypomethylated CpGs relative to all the CpGs represented in the mouse array in brain and liver from Dnmt3a1−/− and Dnmt3a2−/− mice

From: Dnmt3a2 expression during embryonic development is required for phenotypic stability

Hypomethylation %

E15.5

PD 21

Dnmt3a1−/− brain

0.041%

26%

Dnmt3a1−/− liver

0.018%

12%

Dnmt3a2−/− brain

8.1%

1.3%

Dnmt3a2−/− liver

3.8%

1.8%